Cargando…
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic
The Emergency Use Authorization (EUA) originated in 2004 because of the need for emergency medical countermeasures (MCMs) against potential bioterrorist attacks. The EUA also proved useful in dealing with subsequent pandemics and has emerged as a critical regulatory pathway for therapeutics and vacc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401346/ https://www.ncbi.nlm.nih.gov/pubmed/34453703 http://dx.doi.org/10.1007/s40290-021-00397-6 |